Medidata, a leading global provider of cloud-based solutions for clinical research in life sciences, announced the acquisition of Intelemage, a global pioneer in medical image sharing and workflow management. Medidata will integrate Intelemage’s technology into its industry-leading SaaS platform, the Medidata Clinical Cloud, offering customers an end-to-end solution to capture, manage and analyse medical imaging data – the largest and fastest growing data source in the healthcare industry. The transaction was completed in the second quarter of 2016.

Founded in 2007, Intelemage powers medical image file sharing in clinical trials as well as for hospitals, physicians, life sciences companies, research institutions and core labs. The company also provides tools for medical imaging data capture and workflow management. Currently operational in 85 countries and over 5,000 global locations, Intelemage’s technology enables clients to manage all imaging activities in a single environment, providing them with the highest level of control and access to data, performance metrics and other clinical resources. In just the last 12 months, Intelemage has processed 400 million images.

“Imaging technologies play a vital role in evaluating new therapies, allowing clinicians and sponsors to detect diseases, monitor outcomes and predict therapy responses,” said Tarek Sherif, Medidata’s chief executive officer. “Intelemage adds another dimension to the compelling value proposition that is making the Medidata Clinical Cloud an industry standard. We are excited to enter this fast-growing market with next-generation medical imaging capabilities, which – combined with the power of our platform – improve the design, speed, efficiency and analytical rigor of clinical trials, helping to get innovative treatments to patients faster.”

Intelemage’s customers include 14 of the top 15 medical device companies in the world. In acquiring Intelemage, Medidata is enhancing the capabilities of the leading cloud technology platform in the life sciences industry. Medidata technology has transformed clinical trial design and execution and has, to date, supported more than 11,000 clinical studies, 400,000 investigational sites and 2.8 million trial volunteers.

“Using Intelemage’s medical imaging technology has given us the ability to seamlessly capture data, streamline workflows and transfer imaging datasets securely, compliantly and reliably,” said Nicholas Wharton, co-founder and senior vice president of Medical Metrics, an Intelemage customer and partner since 2013 and a leading provider of imaging core lab services for global clinical trials of orthopedic, cardiovascular and neurovascular medical devices, drugs and biologics.

“At a time when clinicians and sponsors are increasingly turning to imaging-based biomarkers to detect and monitor disease and to assess the effectiveness of therapies, it’s exciting to see Intelemage join Medidata. The Medidata platform is transforming clinical research and – with the addition of Intelemage’s cutting-edge capabilities for global image sharing and management – is poised to play an even more significant role in driving the kind of medical innovation that will improve the lives of patients around the world.”